Tag : clinical trial

Clinical Research, Pharma & Healthcare Financing

First Patient Dosed in Phase III Cadonilimab Trial for Gastric CA

PR Newswire
by PR Newswire039
Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating...
Healthcare Quality, Patient Safety & Policy

Manitoba Bioscience Group Applauds Government Support for Research

Business Wire
by Business Wire082
Bioscience Association Manitoba (BAM) welcomes the Manitoba government’s latest announcement to launch a Clinical Trials Office, and the implementation of the Research Manitoba led project,...
Clinical Research, Pharma & Healthcare Financing

Javara, Cape Fear Partner to Expand Clinical Trial Access

Business Wire
by Business Wire058
Dedicated to expanding clinical trial access through collaboration with community-based healthcare systems, Javara today announced a new strategic partnership with Cape Fear Valley Health. Leveraging Javara’s integrated teams...
Clinical Research, Pharma & Healthcare Financing

Lipocine Doses First Patient in Phase 3 Trial for LPCN 1154 PPD

PR Newswire
by PR Newswire099
Phase 3 Top Line Results Expected Q2 2026 Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective...
Healthcare Quality, Patient Safety & Policy

Study Validates Geneoscopy’s ColoSense® Real-World Impact

Business Wire
by Business Wire090
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the publication of a new study...
Clinical Research, Pharma & Healthcare Financing

Dizal Completes Enrollment for Phase III Sunvozertinib NSCLC Study

PR Newswire
by PR Newswire098
Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus...
Public Health, Disease Prevention & Wellness

FRIC Completes Enrollment in TRANSFORM II Trial on Coronary Care

PR Newswire
by PR Newswire0114
Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate...
Clinical Research, Pharma & Healthcare Financing

Everest Medicines Shares Positive Early Data on BTK Inhibitor EVER001

PR Newswire
by PR Newswire0131
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced...
Public Health, Disease Prevention & Wellness

Avidity Reports Positive Phase 1/2 FSHD Data for Del-Brax

PR Newswire
by PR Newswire0108
— Unprecedented data from FORTITUDE™ dose escalation cohorts for del-brax treated participants, compared to placebo, demonstrate improvement in function, strength and PROs as well as rapid...